ARNTL2 and SERPINE1: potential biomarkers for tumor aggressiveness in colorectal cancer

Purpose Cathepsin and plasmin may favor cancer cell invasion degrading extracellular matrix. Plasmin formation from plasminogen is regulated by plasminogen activator inhibitor type-1 (PAI-1). ARNTL2 activates the promoters of the PAI-1 gene, officially called SERPINE1, driving the circadian variatio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cancer research and clinical oncology 2012-03, Vol.138 (3), p.501-511
Hauptverfasser: Mazzoccoli, Gianluigi, Pazienza, Valerio, Panza, Anna, Valvano, Maria Rosa, Benegiamo, Giorgia, Vinciguerra, Manlio, Andriulli, Angelo, Piepoli, Ada
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Purpose Cathepsin and plasmin may favor cancer cell invasion degrading extracellular matrix. Plasmin formation from plasminogen is regulated by plasminogen activator inhibitor type-1 (PAI-1). ARNTL2 activates the promoters of the PAI-1 gene, officially called SERPINE1, driving the circadian variation in circulating PAI-1 levels. Methods We evaluated ARNTL2 and SERPINE1 expression in 50 colorectal cancer specimens and adjacent normal tissue and in colon cancer cell lines. Results We found up-regulation of ARNTL2 ( P  = 0.004) and SERPINE1 ( P  = 0.002) in tumor tissue. A statistically significant association was found between high ARNTL2 mRNA levels and vascular invasion ( P  
ISSN:0171-5216
1432-1335
DOI:10.1007/s00432-011-1126-6